IDSA and the Pew Charitable Trusts hosted a June 9 congressional briefing featuring IDSA Treasurer Helen Boucher, MD, FIDSA, and Lord Jim O’Neill, Chair of the UK Antimicrobial Resistance (AMR) Review. The briefing publicized the UK AMR Review’s final report (PDF), which echoed key IDSA recommendations for incentivizing antibiotic and diagnostics research and development (R&D); strengthening stewardship, surveillance and data collection in human and animal health; and investing in the ID workforce.
Dr. Boucher highlighted the central role of ID physicians in combating resistance and IDSA legislative proposals to spur antibiotic and diagnostic R&D, including the Limited Population Antibacterial Drug (LPAD) bill to allow antibiotics for the most highly resistant pathogens to be studied in smaller clinical trials and approved only for the patients who need them most, and the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act to provide a tax credit for the most urgently needed new antibiotics and rapid diagnostics. You can support this effort by contacting your congressional representatives with a prepared IDSA message
The House Energy and Commerce Oversight and Investigations Subcommittee held a June 14 hearing on progress in the US response to antibiotic resistance, featuring updates
from the Centers for Disease Control and Prevention (CDC), National Institutes of Allergy and Infectious Diseases (NIAID), Food and Drug Administration (FDA), and Biomedical Advanced Research and Development Authority (BARDA). IDSA also briefed
(PDF) committee staff.
The Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
(PACCARB) held a June 21-22 meeting
(PDF) to discuss incentives for antibiotics, diagnostics, vaccines and other therapeutics, as well as antibiotic resistance in agriculture and environmental health. IDSA submitted comments to PACCARB
(PDF) and the Administration
(PDF). IDSA Past President Martin Blaser, MD, FIDSA, chairs the PACCARB, and other IDSA members serving on the PACCARB include Dr. Boucher, Angela Caliendo, MD, FIDSA; Sara Cosgrove, MD, FIDSA and Robert Weinstein, MD, FIDSA.
< Previous Article | Next Article >